Ethicon Endo-Surgery INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.2Mgeneral payments (2019-2025)
$14Kresearch payments (2019-2025)
424clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Stratafix $346K associated (2023-2025)
- Dermabond Prineo $328K associated (2023-2025)
- Monocryl $220K associated (2023-2025)
- Monarch Platform $208K associated (2023-2025)
- Harmonic $110K associated (2023-2025)
- Enseal $104K associated (2023-2025)
- Dermabond $47K associated (2023-2025)
- Neuflex $46K associated (2023-2025)
- Prolene $38K associated (2023-2025)
- Certus 140 $26K associated (2023-2025)
- Echelon Circular $24K associated (2023-2025)
- Pds $19K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Santiago Horgan | San Diego, CA | Surgery | $396,800.00 |
| David Wilson | Seymour, IN | Pulmonary Disease | $384,212.71 |
| Camilla Gomes | San Francisico, CA | Surgery | $294,937.08 |
| Michael Mont | Baltimore, MD | Adult Reconstructive Orthopaedic Surgery | $263,395.25 |
| Paul Laeseke | Madison, WI | Vascular & Interventional Radiology | $90,442.22 |
| Michael Megaly | Minneapolis, MN | Surgery | $90,000.00 |
| Gustavo Cumbo Nacheli | Grand Rapids, MI | Pulmonary Disease | $72,423.41 |
| Ryan Nunley | Saint Louis, MO | Adult Reconstructive Orthopaedic Surgery | $65,835.00 |
| Joseph Whitlark | State College, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $62,115.00 |
| Septimiu Murgu | Chicago, IL | Pulmonary Disease | $57,848.06 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.